S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 96 TWD 1.8% Market Closed
Market Cap: 11.5B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SCI Pharmtech Inc
Revenue Peer Comparison

Comparables:
Y
3705
4746
1789
1795
1720

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Revenue
NT$1.3B
CAGR 3-Years
-9%
CAGR 5-Years
-11%
CAGR 10-Years
-1%
Y
YungShin Global Holding Corp
TWSE:3705
Revenue
NT$7.4B
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
3%
Formosa Laboratories Inc
TWSE:4746
Revenue
NT$4.7B
CAGR 3-Years
14%
CAGR 5-Years
12%
CAGR 10-Years
5%
ScinoPharm Taiwan Ltd
TWSE:1789
Revenue
NT$3.4B
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
-3%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Revenue
NT$16.9B
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
23%
Standard Chem & Pharm Co Ltd
TWSE:1720
Revenue
NT$6.6B
CAGR 3-Years
14%
CAGR 5-Years
12%
CAGR 10-Years
8%

See Also

What is SCI Pharmtech Inc's Revenue?
Revenue
1.3B TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Revenue amounts to 1.3B TWD.

What is SCI Pharmtech Inc's Revenue growth rate?
Revenue CAGR 10Y
-1%

Over the last year, the Revenue growth was 6%. The average annual Revenue growth rates for SCI Pharmtech Inc have been -9% over the past three years , -11% over the past five years , and -1% over the past ten years .

Back to Top